Investigation Report on China Ganglioside Market, 2010-2019
Description
Cardia-cerebrovascular disease is the first big disease with a mortality rate of 20% in the world and over 40% in China. Besides, as most cardia-cerebrovascular diseases are chronic diseases, long-term treatment is needed, which has forced the big market of cardia-cerebrovascular chemicals. As the major varieties of chemicals for the treatment of hypertension, hyperlipidemia and thrombusare are dominated by foreign enterprises, local enterprises have no advantages. However, there are four domestic varieties in the field of vasodilation drugs and neuronprotective agents, among which ganglioside is included.
Ganglioside preparations first came to market in Italy in the 1980s and were marketed into China by TRB Pharma S.A. and TRB Pharma Ind Quimica E Farmaceutica Ltda under the trade name of SYGEN at the end of 1990s. In Nov. 2004, Qilu Pharmaceutical Co., Ltd became the first approved manufacturer of the active pharmaceutical ingredients (APIs) and injection of ganglioside sodium and power-injection under the trade name of Shenjie later. Currently, there are 7 approved manufacturers of ganglioside sodium in China, among which Qilu Pharmaceutical Co., Ltd, Medical University Pharmaceutical Co., Ltd, Beijing Science Sun Pharmaceutical Co., Ltd, Changchun Xiangtong Pharmaceutical Co., Ltd and Wellso Pharmaceutical take the lion’s share.
The marketing of domestic ganglioside injection has improved the breed structure of nervous system drugs and its market share for sales value sales volume has grown fast driven by academic education and product propaganda. For over two years, the wide use of ganglioside injection for the treatment of cerebral apoplexy, child cerebral palsy, dementia and spinal cord injury has further driven the rapid growth of nervous system drugs in hospitals.
According to CRI’s market survey, the sales value of ganglioside in China rose from less than CNY 70 million in 2005 to CNY 1.76 billion in 2014, CAGR during this period reaching up to 44.5%. the market size of ganglioside is expected to keep growing in the next few years in China.
Readers can get at least the following information from this report:
Cardia-cerebrovascular disease is the first big disease with a mortality rate of 20% in the world and over 40% in China. Besides, as most cardia-cerebrovascular diseases are chronic diseases, long-term treatment is needed, which has forced the big market of cardia-cerebrovascular chemicals. As the major varieties of chemicals for the treatment of hypertension, hyperlipidemia and thrombusare are dominated by foreign enterprises, local enterprises have no advantages. However, there are four domestic varieties in the field of vasodilation drugs and neuronprotective agents, among which ganglioside is included.
Ganglioside preparations first came to market in Italy in the 1980s and were marketed into China by TRB Pharma S.A. and TRB Pharma Ind Quimica E Farmaceutica Ltda under the trade name of SYGEN at the end of 1990s. In Nov. 2004, Qilu Pharmaceutical Co., Ltd became the first approved manufacturer of the active pharmaceutical ingredients (APIs) and injection of ganglioside sodium and power-injection under the trade name of Shenjie later. Currently, there are 7 approved manufacturers of ganglioside sodium in China, among which Qilu Pharmaceutical Co., Ltd, Medical University Pharmaceutical Co., Ltd, Beijing Science Sun Pharmaceutical Co., Ltd, Changchun Xiangtong Pharmaceutical Co., Ltd and Wellso Pharmaceutical take the lion’s share.
The marketing of domestic ganglioside injection has improved the breed structure of nervous system drugs and its market share for sales value sales volume has grown fast driven by academic education and product propaganda. For over two years, the wide use of ganglioside injection for the treatment of cerebral apoplexy, child cerebral palsy, dementia and spinal cord injury has further driven the rapid growth of nervous system drugs in hospitals.
According to CRI’s market survey, the sales value of ganglioside in China rose from less than CNY 70 million in 2005 to CNY 1.76 billion in 2014, CAGR during this period reaching up to 44.5%. the market size of ganglioside is expected to keep growing in the next few years in China.
Readers can get at least the following information from this report:
- market size of ganglioside in China
- competitive landscape of ganglioside in Chinese market
- price of ganglioside made by different enterprises in China
- market outlook of ganglioside in China
- manufacturers of nervous system drugs
- investors/ research institutions interested in Chinese medicine market
- any interest in the Chinese medicine market, please contact CRI for customized survey service
1 RELATED CONCEPTS OF GANGLIOSIDE
1.1 Indication
1.2 Sales Status in Global Market
2 MARKET PROFILE OF GANGLIOSIDE IN CHINA
2.1 Patent and Approval Status of Ganglioside in China
2.2 Major Manufacturers
2.3 Market Size
3 SURVEY ON SALES STATUS OF GANGLIOSIDE IN CHINA, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions
4 SURVEY ON MARKET SHARE OF MAJOR MANUFACTURERS OF GANGLIOSIDE IN CHINA, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume
5 SURVEY ON DOSAGE FORMS OF GANGLIOSIDE IN CHINA, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume
6 REFERENCE PRICE OF GANGLIOSIDE IN CHINESE HOSPITALS IN 2014
6.1 TRB Pharma Ind Quimica E Farmaceutica Ltda (Brazil)
6.2 TRB Pharma S.A. (Argentina) (Trade Name: SYGEN)
6.3 Wellso Pharmaceutical (Trade Name: Aogan)
6.4 Beijing Science Sun Pharmaceutical Co., Ltd
6.5Jilin Yinglian Biopharmaceutical Co., Ltd
6.6 Qilu Pharmaceutical Co., Ltd (Trade Name: Shenjie)
6.7 Southwest Pharmaceutical Co., Ltd
6.8 Changchun Xiangtong Pharmaceutical Co., Ltd
6.9 Medical University Pharmaceutical Co., Ltd (Trade Name: Bosijie)
7 MAJOR MANUFACTURERS OF GANGLIOSIDE IN CHINESE MARKET, 2010-2014
7.1 Qilu Pharmaceutical Co., Ltd
7.2 Medical University Pharmaceutical Co., Ltd
7.3 Beijing Science Sun Pharmaceutical Co., Ltd
7.4 Changchun Xiangtong Pharmaceutical Co., Ltd
7.5 Wellso Pharmaceutical
8 MARKET OUTLOOK OF GANGLIOSIDE IN CHINA, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape
1.1 Indication
1.2 Sales Status in Global Market
2 MARKET PROFILE OF GANGLIOSIDE IN CHINA
2.1 Patent and Approval Status of Ganglioside in China
2.2 Major Manufacturers
2.3 Market Size
3 SURVEY ON SALES STATUS OF GANGLIOSIDE IN CHINA, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions
4 SURVEY ON MARKET SHARE OF MAJOR MANUFACTURERS OF GANGLIOSIDE IN CHINA, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume
5 SURVEY ON DOSAGE FORMS OF GANGLIOSIDE IN CHINA, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume
6 REFERENCE PRICE OF GANGLIOSIDE IN CHINESE HOSPITALS IN 2014
6.1 TRB Pharma Ind Quimica E Farmaceutica Ltda (Brazil)
6.2 TRB Pharma S.A. (Argentina) (Trade Name: SYGEN)
6.3 Wellso Pharmaceutical (Trade Name: Aogan)
6.4 Beijing Science Sun Pharmaceutical Co., Ltd
6.5Jilin Yinglian Biopharmaceutical Co., Ltd
6.6 Qilu Pharmaceutical Co., Ltd (Trade Name: Shenjie)
6.7 Southwest Pharmaceutical Co., Ltd
6.8 Changchun Xiangtong Pharmaceutical Co., Ltd
6.9 Medical University Pharmaceutical Co., Ltd (Trade Name: Bosijie)
7 MAJOR MANUFACTURERS OF GANGLIOSIDE IN CHINESE MARKET, 2010-2014
7.1 Qilu Pharmaceutical Co., Ltd
7.2 Medical University Pharmaceutical Co., Ltd
7.3 Beijing Science Sun Pharmaceutical Co., Ltd
7.4 Changchun Xiangtong Pharmaceutical Co., Ltd
7.5 Wellso Pharmaceutical
8 MARKET OUTLOOK OF GANGLIOSIDE IN CHINA, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape
SELECTED CHARTS
Chart Approval Information of Ganglioside in China
Chart Sales Status of Ganglioside in China, 2010-2014
Chart Sales Value of Ganglioside in China, 2010-2014
Chart Sales Value of Ganglioside in Some Regions in China, 2010-2014
Chart Sales Volume of Ganglioside in China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Ganglioside for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Ganglioside Made by Qilu Pharmaceutical Co., Ltd in China, 2010-2014
Chart Sales Value and Market Share of Ganglioside Made by Medical University Pharmaceutical in China, 2010-2014
Chart Sales Value and Market Share of Ganglioside Made by Beijing Science Sun Pharmaceutical in China, 2010-2014
Chart Sales Value and Market Share of Ganglioside Made by Changchun Xiangtong in China, 2010-2014
Chart Sales Value and Market Share of Ganglioside Made by Wellso Pharmaceutical in China, 2010-2014
Chart Price of Ganglioside Made by TRB Pharma Ind Quimica E Farmaceutica Ltda (Brazil) in Some Chinese Cities in 2014
Chart Price of Ganglioside Made by TRB Pharma S.A. (Argentina) in Some Chinese Cities in 2014
Chart Price of Ganglioside Made by Wellso Pharmaceutical in Some Chinese Cities in 2014
Chart Price of Ganglioside Made by Beijing Science Sun Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Ganglioside Made by Jilin Yinglian Biopharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Ganglioside Made by Qilu Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Approval Information of Ganglioside in China
Chart Sales Status of Ganglioside in China, 2010-2014
Chart Sales Value of Ganglioside in China, 2010-2014
Chart Sales Value of Ganglioside in Some Regions in China, 2010-2014
Chart Sales Volume of Ganglioside in China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Ganglioside for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Ganglioside Made by Qilu Pharmaceutical Co., Ltd in China, 2010-2014
Chart Sales Value and Market Share of Ganglioside Made by Medical University Pharmaceutical in China, 2010-2014
Chart Sales Value and Market Share of Ganglioside Made by Beijing Science Sun Pharmaceutical in China, 2010-2014
Chart Sales Value and Market Share of Ganglioside Made by Changchun Xiangtong in China, 2010-2014
Chart Sales Value and Market Share of Ganglioside Made by Wellso Pharmaceutical in China, 2010-2014
Chart Price of Ganglioside Made by TRB Pharma Ind Quimica E Farmaceutica Ltda (Brazil) in Some Chinese Cities in 2014
Chart Price of Ganglioside Made by TRB Pharma S.A. (Argentina) in Some Chinese Cities in 2014
Chart Price of Ganglioside Made by Wellso Pharmaceutical in Some Chinese Cities in 2014
Chart Price of Ganglioside Made by Beijing Science Sun Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Ganglioside Made by Jilin Yinglian Biopharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Ganglioside Made by Qilu Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
